L L Augsburger - JoVE Visualize

Showing results (11-20 of 29) with videos related to

Pageof 3

Sort By:

Pharmaceutical Research|January 1, 1990

Intrinsic dissolution rates of tablet filler-binders and their influence on the dissolution of drugs from tablet formulationsA D Koparkar, L L Augsburger, R F Shangraw

AAPS Pharmsci|December 14, 2001

Estimation of capping incidence by indentation fracture testsR Kuppuswamy, S R Anderson, L L Augsburger, et al.

The Journal of Pharmacy and Pharmacology|February 1, 1995

Tableting characteristics of micro-aggregated egg albumin particles containing paracetamolJ J Torrado-Durán, S Torrado, R Cadórniga, et al.

Pharmaceutical Research|April 1, 1995

Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronizationR D Shah, M Kabadi, D G Pope, et al.

Pharmaceutical Development and Technology|January 5, 2002

Practical limitations of tableting indicesR Kuppuswamy, S R Anderson, S W Hoag, et al.

AAPS Pharmsci|December 14, 2001

Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30DA Y Lin, N A Muhammad, D Pope, et al.

Pharmaceutical Research|March 1, 1994

Physicomechanical characterization of the extrusion-spheronization process. I. Instrumentation of the extruderR D Shah, M Kabadi, D G Pope, et al.

Pharmaceutical Development and Technology|December 1, 1996

Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristicsR M Iyer, L L Augsburger, D G Pope, et al.

Journal of Pharmaceutical Sciences|June 1, 1997

Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tabletsJ E Polli, G S Rekhi, L L Augsburger, et al.

AAPS Pharmscitech|January 20, 2004

Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulationsN D Eddington, G S Rekhi, L J Lesko, et al.

Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:

Pageof 3

Pharmaceutical Research|January 1, 1990

Intrinsic dissolution rates of tablet filler-binders and their influence on the dissolution of drugs from tablet formulationsA D Koparkar, L L Augsburger, R F Shangraw

AAPS Pharmsci|December 14, 2001

Estimation of capping incidence by indentation fracture testsR Kuppuswamy, S R Anderson, L L Augsburger, et al.

The Journal of Pharmacy and Pharmacology|February 1, 1995

Tableting characteristics of micro-aggregated egg albumin particles containing paracetamolJ J Torrado-Durán, S Torrado, R Cadórniga, et al.

Pharmaceutical Research|April 1, 1995

Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronizationR D Shah, M Kabadi, D G Pope, et al.

Pharmaceutical Development and Technology|January 5, 2002

Practical limitations of tableting indicesR Kuppuswamy, S R Anderson, S W Hoag, et al.

AAPS Pharmsci|December 14, 2001

Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30DA Y Lin, N A Muhammad, D Pope, et al.

Pharmaceutical Research|March 1, 1994

Physicomechanical characterization of the extrusion-spheronization process. I. Instrumentation of the extruderR D Shah, M Kabadi, D G Pope, et al.

Pharmaceutical Development and Technology|December 1, 1996

Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristicsR M Iyer, L L Augsburger, D G Pope, et al.

Journal of Pharmaceutical Sciences|June 1, 1997

Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tabletsJ E Polli, G S Rekhi, L L Augsburger, et al.

AAPS Pharmscitech|January 20, 2004

Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulationsN D Eddington, G S Rekhi, L J Lesko, et al.

Pageof 3